A European Commission official stated that onshoring drug manufacture is not the goal of efforts to address drug shortages in the EU. The COVID-19 pandemic highlighted the EU's reliance on non-EU countries for essential medicines, leading to initiatives like the Critical Medicines Alliance to strengthen supply chains. Despite calls for reshoring, the focus remains on international cooperation and partnerships rather than increasing internal production. Teljes cikk (Euronews.com)